The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness of third- or later-line therapy in patients with HER2-positive advanced gastric cancer: Results from an observational retrospective study in Japan.
 
Takeshi Omori
Honoraria - DAIICHI SANKYO COMPANY, LIMITED
Research Funding - DAIICHI SANKYO COMPANY, LIMITED (Inst)
 
Daisuke Sakai
Speakers' Bureau - Chugai Pharma
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo; Eisai (Inst); Incyte (Inst); Lilly Japan; Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Soichi Fumita
Research Funding - Daiichi Sankyo (Inst)
 
Junya Fujita
Research Funding - Daiichi Sankyo (Inst)
 
Ryohei Kawabata
Research Funding - Daiichi Sankyo/UCB Japan (Inst)
 
Jin Matsuyama
Research Funding - Daiichi Sankyo Co., Ltd. (Inst)
 
Hisateru Yasui
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Astellas Pharma (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Motohiro Hirao
Research Funding - Daiichi Sankyo (Inst)
 
Tomono Kawase
Research Funding - Daiichi Sankyo (Inst)
 
Kentaro Kishi
Research Funding - Daiichi Sankyo (Inst)
 
Hirokazu Taniguchi
Research Funding - Daiichi Sankyo (Inst)
 
Yasuhiro Miyazaki
Speakers' Bureau - Otsuka
Research Funding - Daiichi Sankyo (Inst)
 
Tomoko Miura
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
Research Funding - Daiichi Sankyo (Inst)
 
Akimitsu Miyake
Research Funding - Daiichi Sankyo (Inst)
 
Yukinori Kurokawa
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; MC Medical; Medtronic; Nippon Kayaku; Olympus; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Intuitive Surgical (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Makoto Yamasaki
Research Funding - Daiichi Sankyo (Inst)
 
Tomomi Yamada
Research Funding - Daiichi Sankyo (Inst)
 
Taroh Satoh
Honoraria - Astellas Pharma; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Daiihi-Sankyo; Lilly; Merck; Merck Serono; Nihonkayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Nihonkayaku; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Gilead Sciences (Inst); IQVIA (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)
 
Hidetoshi Eguchi
Research Funding - Daiichi Sankyo (Inst)
 
Yuichiro Doki
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly Japan; MSD; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha